Skip to main content
ImmuneCited

Curcumin 관련 Chronic Inflammation

A

An umbrella meta-analysis of 10 studies with 5,870 participants demonstrates curcumin supplementation may significantly reduce CRP, IL-6, and TNF-alpha inflammatory markers. Piperine co-administration increases bioavailability by approximately 2,000%.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dcurcumin\u0026condition\u003Dchronic\u002Dinflammation'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

결론

An umbrella meta-analysis of 10 studies with 5,870 participants demonstrates curcumin supplementation may significantly reduce CRP, IL-6, and TNF-alpha inflammatory markers. Piperine co-administration increases bioavailability by approximately 2,000%.

Key Study Findings

Review
Therapeutic potential of curcumin against pancreatitis.
Dose: None vs: None Outcome: curcumin effects on pancreatitis via anti-inflammatory and antioxidant … 효과: None None

대상 집단: None

Review
Protective Role of Dietary Polyphenols in the Management and Treatment of Type 2 Diabetes Mellitus.
Dose: None vs: None Outcome: None 효과: None None

대상 집단: review of dietary polyphenols in type 2 diabetes mellitus management

Review
Anti-Inflammatory Actions of Plant-Derived Compounds and Prevention of Chronic Diseases: From Molecular Mechanisms to Applications.
Dose: None vs: None Outcome: None 효과: None None

대상 집단: review of plant-derived anti-inflammatory compounds for chronic disease prevention

Review
Pathological interplay of NF-κB and M1 macrophages in chronic inflammatory lung diseases.
Dose: None vs: None Outcome: None 효과: None None

대상 집단: review of NF-kB and M1 macrophages in asthma, COPD, and pulmonary fibrosis

Review
Modulating Ferroptosis in Aging: The Therapeutic Potential of Natural Products.
Dose: None vs: None Outcome: None 효과: None None

대상 집단: None

Review
Curcumin Modulation of the Gut-Brain Axis for Neuroinflammation and Metabolic Disorders Prevention and Treatment.
Dose: None vs: None Outcome: None 효과: None None

대상 집단: None

Key Statistics

10

연구

5870

참여자

Positive

A

등급

Referenced Papers

Antioxidants (Basel, Switzerland) 2025 8 인용
Biomedicines 2021 228 인용
Frontiers in medicine 2021 13 인용
Advances in experimental … 2021 6 인용
European journal of … 2020 91 인용
Current medicinal chemistry 2018 13 인용
Current pharmaceutical design 2017 168 인용
Molecules (Basel, Switzerland) 2015 539 인용
BioFactors (Oxford, England) 2013 288 인용
BioFactors (Oxford, England) 2013 167 인용
Current drug targets 2006 92 인용

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

general:
500-1,000 mg/day curcuminoids
enhancedabsorption:
150-500 mg/day (phytosome or piperine formulation)

상한량: No established UL; generally well-tolerated up to 8 g/day

연구에서 사용된 용량

용량 기간 효과 N
None -- Positive --
None -- Positive --
None -- Positive --
None -- Neutral --
None -- Mixed --
None -- Mixed --
None -- Mixed --
None -- Mixed --

권장 복용 시간: With meals containing fat and black pepper (piperine) for enhanced absorption

Safety & Side Effects

보고된 부작용

  • Gastrointestinal discomfort (nausea, diarrhea, bloating)
  • Headache
  • Yellow stool discoloration
  • Iron absorption interference at very high doses

알려진 상호작용

  • Anticoagulants and antiplatelet drugs (may increase bleeding risk)
  • Diabetes medications (may enhance blood sugar lowering)
  • CYP1A2, CYP3A4, CYP2D6 substrates (may inhibit metabolism)
  • Sulfasalazine and cyclophosphamide (may modify effects)

일일 최대 섭취 허용량: No established UL; generally well-tolerated up to 8 g/day

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does Curcumin help with Chronic Inflammation?
Based on 10 studies with 5,870 participants, there is strong evidence from multiple clinical trials that Curcumin may support Chronic Inflammation management. Our evidence grade is A (Strong Evidence).
How much Curcumin should I take for Chronic Inflammation?
Studies have used various dosages. A commonly studied range is 500-1,000 mg/day curcuminoids. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Curcumin?
Reported side effects may include Gastrointestinal discomfort (nausea, diarrhea, bloating), Headache, Yellow stool discoloration, Iron absorption interference at very high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Curcumin and Chronic Inflammation?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 10 peer-reviewed studies with 5,870 total participants. The overall direction of effect is positive.

Related Evidence

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.